Your browser is no longer supported. Please, upgrade your browser.
Settings
TXMD TherapeuticsMD, Inc. daily Stock Chart
TXMD [NASD]
TherapeuticsMD, Inc.
Index- P/E- EPS (ttm)-0.71 Insider Own7.60% Shs Outstand250.49M Perf Week-4.55%
Market Cap683.84M Forward P/E- EPS next Y-0.37 Insider Trans0.96% Shs Float198.45M Perf Month24.66%
Income-169.70M PEG- EPS next Q-0.19 Inst Own80.30% Short Float41.72% Perf Quarter-14.15%
Sales18.60M P/S36.77 EPS this Y-57.50% Inst Trans0.40% Short Ratio22.82 Perf Half Y-49.82%
Book/sh0.03 P/B91.00 EPS next Y50.00% ROA-77.40% Target Price11.33 Perf Year-51.42%
Cash/sh0.73 P/C3.74 EPS next 5Y19.50% ROE-225.90% 52W Range1.82 - 6.94 Perf YTD-28.35%
Dividend- P/FCF- EPS past 5Y-21.50% ROI-76.20% 52W High-60.66% Beta1.49
Dividend %- Quick Ratio5.00 Sales past 5Y12.90% Gross Margin80.30% 52W Low50.00% ATR0.23
Employees241 Current Ratio5.20 Sales Q/Q60.50% Oper. Margin- RSI (14)55.04 Volatility7.84% 10.11%
OptionableYes Debt/Eq23.96 EPS Q/Q-49.30% Profit Margin- Rel Volume0.55 Prev Close2.80
ShortableYes LT Debt/Eq23.96 EarningsAug 06 AMC Payout- Avg Volume3.63M Price2.73
Recom1.90 SMA208.57% SMA509.19% SMA200-32.83% Volume1,995,951 Change-2.50%
Apr-30-19Resumed Noble Capital Markets Outperform $13
Jun-15-18Initiated JP Morgan Overweight $11
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
Nov-22-16Initiated Oppenheimer Outperform
Nov-07-16Resumed Guggenheim Buy
Apr-04-16Initiated Goldman Buy $10
Dec-08-15Reiterated Stifel Buy $10 → $14
Dec-08-15Reiterated Jefferies Buy $15 → $18
Sep-21-15Reiterated Jefferies Buy $7 → $15
Jun-09-15Initiated Guggenheim Buy
Jul-08-14Initiated FBR Capital Outperform $34
Apr-17-14Reiterated Noble Financial Buy $9 → $13
Jan-28-14Reiterated Noble Financial Buy $7.25 → $9
Nov-01-13Initiated Stifel Buy $8
Aug-21-19 10:06AM  Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
07:30AM  Analysts Expect Breakeven For TherapeuticsMD, Inc. (NASDAQ:TXMD) Simply Wall St.
Aug-20-19 09:13PM  TherapeuticsMD agrees to pay $200,000 to settle SEC charges American City Business Journals
08:15PM  Therapeuticsmd Inc (TXMD) CEO Robert G Finizio Bought $95,900 of Shares GuruFocus.com
04:53PM  TherapeuticsMD agrees to pay $200,000 to settle SEC charges American City Business Journals
10:46AM  TherapeuticsMD stock slides 6% after SEC charges company with breaking disclosure rules MarketWatch
Aug-12-19 07:15PM  Therapeuticsmd Inc (TXMD) CEO Robert G Finizio Bought $155,119 of Shares GuruFocus.com
Aug-09-19 01:35PM  Edited Transcript of TXMD earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents +17.42%
Aug-07-19 04:00PM  Here's Why TherapeuticsMD Stock Is Jumping Today Motley Fool +20.86%
Aug-06-19 10:24PM  TherapeuticsMD Inc (TXMD) Q2 2019 Earnings Call Transcript Motley Fool
06:15PM  TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM  TherapeuticsMD Announces Second Quarter 2019 Financial Results Business Wire
Jul-25-19 07:00AM  TherapeuticsMD to Report Second Quarter 2019 Results on August 6, 2019 Business Wire
Jul-22-19 10:31AM  Earnings Preview: TherapeuticsMD (TXMD) Q2 Earnings Expected to Decline Zacks
Jul-16-19 08:21AM  Before You Buy TherapeuticsMD, Inc. (NASDAQ:TXMD), Consider Its Volatility Simply Wall St.
Jun-14-19 06:08PM  Edited Transcript of TXMD earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents -5.43%
Jun-12-19 07:25AM  Jim Cramer Shares His Thoughts On TherapeuticsMD, Rite Aid And More Benzinga
Jun-10-19 09:39AM  TherapeuticsMD Enters Agreement to Market Drugs Outside US Zacks
07:00AM  TherapeuticsMD to Host Investor and Analyst Day Today Business Wire
Jun-07-19 07:15AM  TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA and IMVEXXY® Outside the United States Business Wire
May-29-19 07:00AM  TherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City Business Wire
May-08-19 07:00AM  TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference Business Wire
May-07-19 02:06PM  Here's Why TherapeuticsMD Fell as Much as 17.6% Today Motley Fool -16.48%
May-06-19 10:14PM  TherapeuticsMD Inc (TXMD) Q1 2019 Earnings Call Transcript Motley Fool
06:45PM  TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates Zacks
05:33PM  TherapeuticsMD: 1Q Earnings Snapshot Associated Press
04:05PM  TherapeuticsMD Announces First Quarter 2019 Financial Results Business Wire
08:50AM  Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
07:00AM  TherapeuticsMD Presented New Research at the American College of Obstetricians and Gynecologists 2019 Annual Meeting that Explores How Womens Menopausal Symptoms Affect Men Business Wire
May-03-19 10:38AM  Is TherapeuticsMD Inc (TXMD) A Good Stock To Buy? Insider Monkey
07:00AM  TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA and ANNOVERA at the American College of Obstetricians and Gynecologists 2019 Annual Meeting Business Wire
May-02-19 07:20AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TherapeuticsMD, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Apr-29-19 07:00AM  TherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019 Business Wire
Apr-25-19 10:33AM  Analysts Estimate TherapeuticsMD (TXMD) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-24-19 04:10PM  TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners Business Wire
Apr-17-19 07:05AM  TherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners Business Wire
07:00AM  TherapeuticsMD Announces Commercial Availability of BIJUVA in the U.S. Business Wire
Apr-12-19 12:08PM  Is TherapeuticsMD, Inc. (NASDAQ:TXMD) Overpaying Its CEO? Simply Wall St.
Apr-06-19 08:03AM  Here's Why Investors Are Betting Against These 2 Biotech Stocks Motley Fool
Mar-25-19 07:00AM  TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA and ANNOVERA at the Endocrine Society 2019 Annual Meeting Business Wire
Mar-08-19 07:00AM  TherapeuticsMD Announces Oral Presentations on BIJUVA and ANNOVERA, and Poster Presentations Related to Menopause Symptoms and Treatments at 2019 ISSWSH/ISSM Joint Meeting Business Wire
Mar-05-19 08:35AM  Consolidated Research: 2019 Summary Expectations for TherapeuticsMD, Ensco plc, Cray, BeiGene, The Gap, and Nordson Fundamental Analysis, Key Performance Indications GlobeNewswire
Mar-01-19 12:16AM  Edited Transcript of TXMD earnings conference call or presentation 21-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-28-19 07:00AM  TherapeuticsMD Announces Participation in Two Upcoming Investor Conferences Business Wire
Feb-25-19 09:03AM  TherapeuticsMD (TXMD) Catches Eye: Stock Jumps 6.1% Zacks
Feb-22-19 09:11AM  TherapeuticsMD, Inc. (TXMD) Q4 2018 Earnings Conference Call Transcript Motley Fool +6.09%
08:50AM  The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data Benzinga
Feb-21-19 05:59PM  TherapeuticsMD: 4Q Earnings Snapshot Associated Press -6.78%
04:05PM  TherapeuticsMD Announces Fourth Quarter and Full-Year 2018 Financial Results Business Wire
01:55PM  Is TherapeuticsMD, Inc.s (NASDAQ:TXMD) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Feb-08-19 07:00AM  TherapeuticsMD to Report Fourth Quarter and Full Year 2018 Results on February 21, 2019 Business Wire
Feb-04-19 09:46PM  Here's What Pushed TherapeuticsMD 37.8% Higher in January Motley Fool +6.86%
Jan-17-19 08:51AM  Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
Jan-10-19 03:17PM  Why TherapeuticsMD's Stock Spiked Today Motley Fool +12.56%
Jan-03-19 07:00AM  TherapeuticsMD Announces Participation at 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-21-18 12:40PM  The Charts of TherapeuticsMD Look Bearish to Me TheStreet.com
07:18AM  Jim Cramer Weighs In On Palo Alto, Blackstone And More Benzinga
Dec-20-18 06:54PM  Cramer's lightning round: These cybersecurity stocks are the ones to own in this market CNBC -7.05%
11:19AM  Is TherapeuticsMD Inc (TXMD) A Good Stock To Buy? Insider Monkey
Dec-03-18 08:00AM  Detailed Research: Economic Perspectives on TESARO, Regeneron Pharmaceuticals, Pool, Zebra Technologies, Cadence Design, and TherapeuticsMD What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-19-18 01:00PM  Fast-growing pharmaceutical company signs $20M lease to expand Boca Raton HQ American City Business Journals
Nov-12-18 04:30PM  TherapeuticsMD Announces Participation in Three Upcoming Investor Conferences Business Wire
Nov-08-18 03:53AM  Edited Transcript of TXMD earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents +6.42%
Nov-07-18 06:12PM  TherapeuticsMD: 3Q Earnings Snapshot Associated Press
04:05PM  TherapeuticsMD Announces Third Quarter 2018 Financial Results Business Wire
Nov-06-18 01:12PM  TherapeuticsMD Incs (NASDAQ:TXMD) Profit Outlook Simply Wall St.
Oct-30-18 07:00AM  TherapeuticsMD to Report Third Quarter 2018 Financial Results on November 7, 2018 Business Wire
Oct-29-18 03:04PM  Why TherapeuticsMD Is Sinking Despite Sharing Good News Motley Fool -6.48%
10:31AM  TherapeuticsMD (TXMD) Q3 Earnings Preview: What to Watch Ahead of the Release Zacks
08:00AM  Today's Research Reports on Trending Tickers: TherapeuticsMD and Horizon Pharma Public ACCESSWIRE
06:27AM  U.S. FDA approves TherapeuticsMD's menopause drug Reuters
06:00AM  TherapeuticsMD Announces FDA Approval of TX-001HR: BIJUVA (Estradiol and Progesterone) Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause Business Wire
Oct-24-18 08:25AM  Consolidated Research: 2018 Summary Expectations for Novavax, Caesars Entertainment, SeaWorld Entertainment, LendingTree, CVS Health, and TherapeuticsMD Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-16-18 06:33AM  3 Biotechs Awaiting FDA Approval Decisions Motley Fool +7.57%
Oct-11-18 10:30AM  Cannabis and Biotech Stocks That Have Run Parabolically ACCESSWIRE
Sep-28-18 08:32AM  Today's Research Reports on Trending Tickers: TherapeuticsMD and Endo International ACCESSWIRE
07:00AM  TherapeuticsMD Announces Multiple Presentations Related to Imvexxy and TX-001HR at the 2018 Annual Meeting of the North American Menopause Society Business Wire
Sep-27-18 04:05PM  TherapeuticsMD Enters Into Label Discussions for TX-001HR Business Wire
Sep-26-18 08:30AM  Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
Sep-25-18 07:00AM  TherapeuticsMD to Present at 2018 Cantor Global Healthcare Conference Business Wire
Sep-20-18 07:00AM  TherapeuticsMD Announces the FDA has Granted AnnoveraTM Marketing Exclusivity as a New Chemical Entity Business Wire +8.52%
Sep-13-18 07:00AM  TherapeuticsMD Announces Commercial Availability of Imvexxy 4 mcg Business Wire
Sep-12-18 12:56PM  What You Must Know About TherapeuticsMD Incs (NASDAQ:TXMD) Market Risks Simply Wall St.
Sep-11-18 10:30AM  High Value Cannabis and Biotech Stocks ACCESSWIRE
Sep-10-18 12:22PM  Here's Why TherapeuticsMD Jumped 24.1% in August Motley Fool
Aug-22-18 07:00AM  TherapeuticsMD to Present at 13th Annual Wells Fargo Securities Healthcare Conference Business Wire
Aug-17-18 12:48PM  Edited Transcript of TXMD earnings conference call or presentation 30-Jul-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-15-18 08:25PM  Key FDA Decisions Could Power These 3 Biopharma Stocks SmarterAnalyst
Aug-10-18 04:09PM  FDA Approves New Form Of Self-Administered Female Birth Control Benzinga
03:05PM  TherapeuticsMD Announces FDA Approval of ANNOVERA (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control Business Wire
Aug-09-18 05:48AM  TherapeuticsMD Receives Bullish Note From Street on New Found Potential Investopedia
Aug-06-18 04:05PM  TherapeuticsMD Announces Closing of its Underwritten Public Offering and Concurrent Registered Direct Offering of Common Stock Business Wire
Aug-01-18 09:36PM  TherapeuticsMD Announces Pricing of Its Underwritten Public Offering and Concurrent Registered Direct Offering for Aggregate Gross Proceeds of $85 Million Business Wire
Jul-31-18 04:15PM  TherapeuticsMD Licenses Population Councils Novel Segesterone Acetate/ Ethinyl Estradiol One-Year Vaginal Contraceptive System Business Wire -5.43%
04:13PM  Knight Therapeutics and TherapeuticsMD Announce Strategic Partnership Business Wire
04:09PM  TherapeuticsMD Announces Proposed $65 Million Underwritten Public Offering and Concurrent $20 Million Registered Direct Offering of Common Stock Business Wire
Jul-30-18 06:30AM  TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE -9.21%
06:15AM  TherapeuticsMD Announces Second Quarter 2018 Financial Results Business Wire
Jul-25-18 07:00AM  TherapeuticsMD to Report Second Quarter 2018 Financial Results on July 30, 2018 Business Wire
Jul-17-18 07:30AM  Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks ACCESSWIRE
TherapeuticsMD, Inc. operates as a women's health care product company in the United States. The company's hormone therapy drug candidate is the TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil. Its preclinical projects include the development of TX-005HR, a topical progesterone cream; TX-006HR, an estradiol and progesterone topical cream to penetrate human skin; and TX-00THR and TX-0008HR, which are transdermal patch forms. The company also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. In addition, it commercializes IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finizio Robert GCEOAug 20Buy2.7435,00095,90018,253,964Aug 20 05:12 PM
Milligan John C.K. IVPresident/SecretaryAug 16Buy2.9310,00029,3003,582,373Aug 19 04:56 PM
Russell Angus C.DirectorAug 15Buy2.9910,00029,90083,500Aug 15 04:33 PM
Russell Angus C.DirectorAug 14Buy2.7625,00069,00073,500Aug 15 04:33 PM
Milligan John C.K. IVPresident/SecretaryAug 12Buy3.1615,00047,4003,572,373Aug 14 04:32 PM
Barlow Jane FDirectorAug 12Buy3.183,1449,9983,144Aug 14 04:33 PM
Finizio Robert GCEOAug 09Buy2.9652,405155,11918,218,964Aug 12 05:32 PM
Thompson Tommy GDirectorAug 09Buy3.045,00015,200690,900Aug 13 04:33 PM
Bernick BrianDirectorAug 09Buy2.8710,00028,70062,000Aug 13 04:31 PM
Collins Cooper C.DirectorMay 13Buy3.3330,00099,87066,000May 15 05:03 PM
Thompson Tommy GDirectorMay 13Buy3.342,4008,016685,900May 14 06:00 PM
MUSING JULES A.DirectorFeb 27Sale5.8017,400100,9205,000Mar 01 05:30 PM
Finizio Robert GCEODec 20Option Exercise0.1092,9109,45818,459,469Dec 21 08:02 PM
Finizio Robert GCEODec 20Sale3.6392,910336,89218,366,559Dec 21 08:02 PM
Finizio Robert GCEODec 19Option Exercise0.1092,0009,36618,458,559Dec 21 08:02 PM
Finizio Robert GCEODec 19Sale3.7092,000340,21618,366,559Dec 21 08:02 PM
Milligan John C.K. IVPresident/SecretaryDec 18Option Exercise0.10129,12713,1451,601,546Dec 19 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 18Sale3.64129,127469,6351,472,419Dec 19 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 17Option Exercise0.10129,00013,1321,601,419Dec 19 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 17Sale3.75129,000483,7501,472,419Dec 19 08:01 PM
Bernick BrianDirectorDec 13Option Exercise0.1091,9109,3566,649,281Dec 14 08:01 PM
Bernick BrianDirectorDec 13Sale4.1291,910378,5776,557,371Dec 14 08:01 PM
Bernick BrianDirectorDec 12Option Exercise0.1091,4009,3056,648,771Dec 14 08:01 PM
Bernick BrianDirectorDec 12Sale4.1891,400381,9616,557,371Dec 14 08:01 PM
Finizio Robert GCEODec 07Option Exercise0.1092,0009,36618,458,559Dec 10 08:03 PM
Finizio Robert GCEODec 07Sale4.6092,000423,56818,366,559Dec 10 08:03 PM
Milligan John C.K. IVPresident/SecretaryDec 06Option Exercise0.10129,00013,1321,601,419Dec 06 08:01 PM
Finizio Robert GCEODec 06Option Exercise0.1092,0009,36618,458,559Dec 10 08:03 PM
Cartwright Daniel ACFODec 06Option Exercise0.3840,00015,20040,000Dec 10 08:02 PM
Finizio Robert GCEODec 06Sale4.5792,000420,62418,366,559Dec 10 08:03 PM
Cartwright Daniel ACFODec 06Sale4.5740,000182,80040,000Dec 10 08:02 PM
Milligan John C.K. IVPresident/SecretaryDec 06Sale4.57129,000589,5301,472,419Dec 06 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 04Option Exercise0.10129,00013,1321,601,419Dec 06 08:01 PM
Milligan John C.K. IVPresident/SecretaryDec 04Sale4.98129,000642,1621,472,419Dec 06 08:01 PM
Bernick BrianDirectorDec 03Option Exercise0.1091,4009,3056,648,771Dec 04 08:09 PM
Bernick BrianDirectorDec 03Sale5.1891,400473,4526,557,371Dec 04 08:09 PM
Bernick BrianDirectorNov 30Option Exercise0.1091,4009,3056,648,771Dec 04 08:09 PM
Bernick BrianDirectorNov 30Sale4.9691,400453,3446,557,371Dec 04 08:09 PM
Milligan John C.K. IVPresident/SecretaryNov 29Option Exercise0.10129,12813,1451,601,547Nov 30 08:01 PM
Milligan John C.K. IVPresident/SecretaryNov 29Sale5.03129,128650,0301,472,419Nov 30 08:01 PM
Milligan John C.K. IVPresident/SecretaryNov 28Option Exercise0.10129,00013,1321,601,419Nov 30 08:01 PM
Milligan John C.K. IVPresident/SecretaryNov 28Sale4.89129,000630,2941,472,419Nov 30 08:01 PM
Finizio Robert GCEONov 27Option Exercise0.1092,0009,36618,485,559Nov 28 08:01 PM
Finizio Robert GCEONov 27Sale4.8192,000442,06018,393,559Nov 28 08:01 PM
Finizio Robert GCEONov 26Option Exercise0.1092,0009,36618,485,559Nov 28 08:01 PM
Finizio Robert GCEONov 26Sale4.8692,000447,02818,393,559Nov 28 08:01 PM
Bernick BrianDirectorNov 20Option Exercise0.1091,4009,3056,648,771Nov 21 07:01 PM
Bernick BrianDirectorNov 20Sale4.7491,400432,8706,557,371Nov 21 07:01 PM
Bernick BrianDirectorNov 19Option Exercise0.1091,4009,3056,648,771Nov 21 07:01 PM
Bernick BrianDirectorNov 19Sale4.7591,400433,8766,557,371Nov 21 07:01 PM
Milligan John C.K. IVPresident/SecretaryNov 15Option Exercise0.10129,00013,1321,601,419Nov 16 08:02 PM
Milligan John C.K. IVPresident/SecretaryNov 15Sale4.99129,000643,5811,472,419Nov 16 08:02 PM
Milligan John C.K. IVPresident/SecretaryNov 14Option Exercise0.10129,00013,1321,601,419Nov 16 08:02 PM
Milligan John C.K. IVPresident/SecretaryNov 14Sale4.82129,000621,6511,472,419Nov 16 08:02 PM
Finizio Robert GCEONov 13Option Exercise0.1092,0009,36618,485,559Nov 14 08:02 PM
Finizio Robert GCEONov 13Sale4.8192,000442,42818,393,559Nov 14 08:02 PM
Finizio Robert GCEONov 12Option Exercise0.1092,0009,36618,485,559Nov 14 08:02 PM
Finizio Robert GCEONov 12Sale4.7392,000435,16018,393,559Nov 14 08:02 PM
Bernick BrianDirectorNov 09Option Exercise0.1091,4009,3056,648,771Nov 13 08:01 PM
Bernick BrianDirectorNov 09Sale4.8391,400441,0966,557,371Nov 13 08:01 PM
Bernick BrianDirectorNov 08Option Exercise0.1091,4009,3056,648,771Nov 13 08:01 PM
Bernick BrianDirectorNov 08Sale4.9391,400450,2366,557,371Nov 13 08:01 PM
Cartwright Daniel ACFONov 07Option Exercise0.3840,00015,20040,000Nov 13 07:35 AM
Cartwright Daniel ACFONov 07Sale4.8540,000194,0000Nov 13 07:35 AM
Finizio Robert GCEOOct 26Option Exercise0.1092,0009,36618,485,559Oct 29 09:00 PM
Finizio Robert GCEOOct 26Sale5.1292,000470,76418,393,559Oct 29 09:00 PM
Finizio Robert GCEOOct 25Option Exercise0.1092,0009,36618,485,559Oct 29 09:00 PM
Finizio Robert GCEOOct 25Sale5.4592,000501,30818,393,559Oct 29 09:00 PM
Milligan John C.K. IVPresident/SecretaryOct 24Option Exercise0.10125,00012,7251,597,419Oct 25 09:06 PM
Milligan John C.K. IVPresident/SecretaryOct 24Sale5.37125,000671,2501,472,419Oct 25 09:06 PM
Milligan John C.K. IVPresident/SecretaryOct 23Option Exercise0.10125,00012,7251,597,419Oct 25 09:06 PM
Milligan John C.K. IVPresident/SecretaryOct 23Sale5.33125,000666,2501,472,419Oct 25 09:06 PM
Bernick BrianDirectorOct 19Option Exercise0.1091,4009,3056,648,771Oct 22 07:19 PM
Bernick BrianDirectorOct 19Sale5.5191,400503,6146,557,371Oct 22 07:19 PM
Bernick BrianDirectorOct 18Option Exercise0.1091,4009,3056,648,771Oct 22 07:19 PM
Bernick BrianDirectorOct 18Sale5.6191,400512,7546,557,371Oct 22 07:19 PM
Finizio Robert GCEOOct 12Option Exercise0.1092,0009,36618,485,559Oct 15 07:01 PM
Finizio Robert GCEOOct 12Sale5.4592,000501,21618,393,559Oct 15 07:01 PM
Finizio Robert GCEOOct 11Option Exercise0.1092,0009,36618,485,559Oct 15 07:01 PM
Finizio Robert GCEOOct 11Sale5.6592,000519,61618,393,559Oct 15 07:01 PM
Milligan John C.K. IVPresident/SecretaryOct 10Option Exercise0.10125,00012,7251,597,419Oct 11 07:01 PM
Milligan John C.K. IVPresident/SecretaryOct 10Sale5.76125,000719,6251,472,419Oct 11 07:01 PM
Milligan John C.K. IVPresident/SecretaryOct 09Option Exercise0.10125,00012,7251,597,419Oct 11 07:01 PM
Milligan John C.K. IVPresident/SecretaryOct 09Sale5.95125,000743,1251,472,419Oct 11 07:01 PM
Bernick BrianDirectorOct 05Option Exercise0.1091,4009,3056,648,771Oct 09 07:00 PM
Bernick BrianDirectorOct 05Sale5.9391,400542,0026,557,371Oct 09 07:00 PM
Bernick BrianDirectorOct 04Option Exercise0.1091,4009,3056,648,771Oct 09 07:00 PM
Bernick BrianDirectorOct 04Sale5.8991,400538,3466,557,371Oct 09 07:00 PM
Bernick BrianDirectorSep 28Option Exercise0.1091,4009,3056,648,771Oct 01 07:01 PM
Bernick BrianDirectorSep 28Sale6.5591,400598,5796,557,371Oct 01 07:01 PM
Bernick BrianDirectorSep 27Option Exercise0.1091,4009,3056,648,771Oct 01 07:01 PM
Bernick BrianDirectorSep 27Sale6.6391,400605,9826,557,371Oct 01 07:01 PM
Milligan John C.K. IVPresident/SecretarySep 26Option Exercise0.10125,00012,7251,597,419Sep 27 07:02 PM
Milligan John C.K. IVPresident/SecretarySep 26Sale6.78125,000847,0001,472,419Sep 27 07:02 PM
Milligan John C.K. IVPresident/SecretarySep 25Option Exercise0.10125,00012,7251,597,419Sep 27 07:02 PM
Milligan John C.K. IVPresident/SecretarySep 25Sale6.78125,000847,2501,472,419Sep 27 07:02 PM
Finizio Robert GCEOSep 21Option Exercise0.1092,0009,36618,485,559Sep 24 07:01 PM
Finizio Robert GCEOSep 21Sale6.6792,000613,64018,393,559Sep 24 07:01 PM
Finizio Robert GCEOSep 20Option Exercise0.1092,0009,36618,485,559Sep 24 07:01 PM
Finizio Robert GCEOSep 20Sale6.5892,000605,36018,393,559Sep 24 07:01 PM